Search

everythinglearnresearchcommunity

for

Search:↓

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

COVID-19 may cause early hair loss similar to classic temporary hair loss, with further research needed.

COVID-19 may cause temporary hair loss due to direct damage to hair follicles, but it usually gets better on its own.

COVID-19 survivors may face long-term health issues affecting both mind and body.

COVID-19 changed dermatology by increasing telemedicine and highlighting healthcare disparities.

Blocking enzymes that help the virus enter cells could be a promising way to treat COVID-19.

Long-haul COVID can cause lasting symptoms affecting many body systems and may be linked to ongoing inflammation and immune system issues.

The Polish Medical Association in Chicago effectively supported the Polish community during COVID-19.

Healthcare workers with a positive COVID-19 test were more likely to report long-COVID symptoms.

Men's sensitivity to male hormones might affect how severe COVID-19 gets for them.

The IGRA test effectively detects past SARS-CoV-2 exposure, especially using nucleocapsid peptides.

COVID-19 can increase the risk of hair loss, especially in people over 40.

A woman's complete hair loss condition improved after recovering from COVID-19.

COVID-19 may cause temporary hair loss, which usually gets better on its own, but reducing stress and managing health issues might help recovery.

Post-COVID conditions increase health care needs for six months after infection.

People with androgenetic alopecia had milder COVID-19 symptoms during the Omicron wave in China.

COVID-19 can cause temporary hair loss, which is commonly reversible with treatment.

Nirmatrelvir/Ritonavir treatment may lead to a weaker immune response to COVID-19, but doesn't affect the chance of rebound.

Higher testosterone and lower Vitamin D levels are linked to hair loss in female COVID-19 patients.

Long COVID affects over half of COVID-19 survivors, causing a range of symptoms like fatigue and neurological issues, with no specific treatment yet.

Metformin may help mild COVID-19 cases, while Oseltamivir, Tamoxifen, and Dexamethasone are suggested for severe cases.

Healthcare workers with COVID-19 reported more long-term symptoms, and physical activity may help reduce some of these symptoms.

Most people with post-COVID syndrome experience symptoms like fatigue, but Omicron variants cause fewer persistent symptoms.

Computer-aided methods can speed up COVID-19 drug discovery and help find new uses for existing drugs.

Nearly half of the patients had Long COVID, leading to health and work issues, especially in high-risk groups.

Post-COVID syndrome symptoms are common and overlap with general health issues.

More research is needed to understand sex and racial differences in long COVID.

COVID-19 can harm male fertility by reducing sperm stem cells and damaging testicular function.

COVID-19 generally causes fewer complications than influenza, except for certain conditions like hair loss and heart issues.

Long COVID affects many survivors with ongoing symptoms, needing more research and care.